Platelet glycogen synthase kinase 3β regulates plasma β amyloid and phosphorylated tau levels in chronic kidney disease patients with cognitive dysfunction; therapeutic role of erythropoietin

• Κύριοι συγγραφείς: Vinothkumar Ganesan (Συγγραφέας), Krishnakumar Sethuraman (Συγγραφέας), Sureshkumar Sureshkumar (Συγγραφέας), Venkataraman Prabhu (Συγγραφέας)
• Μορφή: Βιβλίο
• Έκδοση: Society of Diabetic Nephropathy Prevention, 2023-09-01T00:00:00Z.
• Θέματα: article
• Διαθέσιμο Online: Connect to this object online.

Introduction: Patients with chronic kidney disease (CKD) have increasingly been diagnosed with cognitive impairment. Glycogen synthase kinase 3β (GSK3β) is directly causing both phosphorylated tau (pTau) and amyloid β (Aβ) accumulation in Alzheimer's disease (AD). GSK3β expression is more abund...